Magnetic nanoparticles break the capacity barrier for antibody purification
Wednesday, August 13, 2014 - 08:30
in Physics & Chemistry
Monoclonal antibodies represent the largest and fastest-growing segment of international biopharma. While these therapeutic agents are a boon for global healthcare, productivity constraints pose a serious challenge for manufacturers seeking to make sufficient amounts for therapeutic applications. Now, A*STAR researchers have developed a high-capacity method to purify monoclonal antibodies that uses magnetic nanoparticles and also introduces new operating conditions.